Jury Gives Merck Another Vioxx Win

Law360, New York (November 15, 2006, 12:00 AM EST) -- A federal jury said Wednesday that Merck & Co. wasn’t liable for a man’s heart attack, handing the drug company a victory in its fight over withdrawn arthritis drug Vioxx.

Charles Laron Mason said he took the drug for the 10 months leading up to his 2003 heart attack.

Vioxx raked in $2.5 billion in sales a year for Merck until the company pulled it from the shelves in September 2004, following a study that found the drug doubled the risk of heart attack and stroke...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.